1380587-34-7

Upstream product

• 586-75-4 4-chlorobenzoyl chloride 
• 1423694-17-0 C₂₉H₂₆N₂O₅ 
• 1380587-35-8 [5-(4-bromophenyl)oxazol-4-yl]carbamic acid (R)-1-phenylethyl ester 
• 127919-32-8 5-(4-bromophenyl)oxazole-4-carboxylic acid ethyl ester 
• 1249008-71-6 5-(4-bromophenyl)oxazole-4-carboxylic acid 
• 586-76-5 4-Bromobenzoic acid 
• 1396007-85-4 1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarboxylic acid methyl ester 
• 638220-35-6 1-(4-bromophenyl)-cyclopropanecarboxylic acid methyl ester 
• 345965-52-8 1-(4-bromophenyl)cyclopropanecarboxylic acid 
• 124276-67-1 1-(4-bromophenyl)cyclopropanecarbonitrile 
• 16532-79-9 4-Bromophenylacetonitrile 

Downstream Products

• 1423694-19-2 C₂₈H₂₃N₂O₅^(1-)*Na⁽¹⁺⁾ 

Relevant academic research and scientific papers

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

Compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or diagnose diseases, disorders, or conditions associated with one or more of the lysophosphatidic acid receptors are provided.

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AND USES THEREOF

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.